- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/26 - Interleukin-2
Patent holdings for IPC class C12N 15/26
Total number of patents in this class: 109
10-year publication summary
|
3
|
2
|
1
|
10
|
15
|
20
|
6
|
7
|
11
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Roche Glycart AG | 140 |
5 |
| Innovent Biologics (Suzhou) Co., Ltd. | 246 |
4 |
| Shanghai Shengdi Pharmaceutical Co., Ltd | 120 |
4 |
| Leto Laboratories Co., Ltd | 18 |
4 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
3 |
| Medicenna Therapeutics Inc. | 38 |
3 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 644 |
3 |
| Tilt Biotherapeutics Oy | 27 |
3 |
| Medikine, Inc. | 40 |
3 |
| Synthorx, Inc. | 77 |
3 |
| Shanghai GP Biotech Co. Ltd. | 4 |
3 |
| Amgen Inc. | 4074 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6408 |
2 |
| Nektar Therapeutics | 435 |
2 |
| ProLynx LLC | 50 |
2 |
| Soonchunhyang University Industry Academy Cooperation Foundation | 180 |
2 |
| Wuxi Biologics (Shanghai) Co. Ltd. | 159 |
2 |
| WuXi Biologics Ireland Limited | 263 |
2 |
| Beijing Jingtai Technology Co., Ltd. | 2 |
2 |
| Fortvita Biologics (Singapore) Pte. Ltd. | 6 |
2 |
| Other owners | 53 |